Science Applications International Corporation (SAIC) Key Metrics
SAIC valuation today
Trailing 12 months · as of October 17, 2026- Market cap
- $5.58B
- Enterprise value
- $8.15B
- P/E (TTM)
- 15.5 10-yr median 19.2
- Forward P/E
- 10.6
- PEG ratio
- 3.67
- Price / sales
- 0.8 10-yr median 0.8
- Price / book
- 3.9 10-yr median 3.6
- EV / EBITDA
- 10.9 10-yr median 13.3
- Dividend yield
- 1.11% $1.48 a year
- Beta
- 0.31
SAIC key metrics, FY2017–FY2026
Fiscal year ended January 31, 2026 · U.S. dollarsSAIC valuation Price multiples at each fiscal year-end price.
SAIC returns How much profit the business earns on the capital it uses.
SAIC per-share figures Results divided by the shares outstanding at year-end.
SAIC financial health Debt, liquidity and how easily interest is covered.
SAIC efficiency & capital use Working capital cycle and where the cash goes.
SAIC valuation history
SAIC returns on capital
Net income (ROE, ROA) or after-tax operating income (ROIC) divided by the average of the opening and closing balance.
SAIC debt vs cash
Debt includes short- and long-term borrowings and, where reported, lease liabilities.
SAIC cash returned to shareholders
SAIC price vs earnings per share
SAIC key metrics
FY2017–FY2026| FY2026 | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Valuation | ||||||||||
| Market capitalization | $4.73B | $5.47B | $6.86B | $5.79B | $4.77B | $5.64B | $5.18B | $2.96B | $3.41B | $3.74B |
| Enterprise value | $7.26B | $7.81B | $9.01B | $8.21B | $7.37B | $8.19B | $7.08B | $4.81B | $4.29B | $4.57B |
| P/E ratio | 13.2 | 15.1 | 14.4 | 19.3 | 17.2 | 27.0 | 22.9 | 21.6 | 19.1 | 26.1 |
| Price / sales | 0.7 | 0.7 | 0.9 | 0.8 | 0.6 | 0.8 | 0.8 | 0.6 | 0.8 | 0.8 |
| Price / book | 3.2 | 3.5 | 3.8 | 3.4 | 2.9 | 3.7 | 3.7 | 2.0 | 10.4 | 10.7 |
| Price / free cash flow | 8.2 | 11.9 | 18.6 | 11.4 | 9.9 | 8.0 | 11.8 | 19.0 | 17.5 | 14.5 |
| Price / operating cash flow | 7.8 | 11.1 | 17.3 | 10.9 | 9.2 | 7.5 | 11.3 | 16.1 | 15.7 | 13.7 |
| EV / sales | 1.0 | 1.0 | 1.2 | 1.1 | 1.0 | 1.2 | 1.1 | 1.0 | 1.0 | 1.0 |
| EV / EBITDA | 11.0 | 11.4 | 10.2 | 12.6 | 11.7 | 14.3 | 14.0 | 17.8 | 14.1 | 14.4 |
| EV / free cash flow | 12.6 | 17.0 | 24.4 | 16.2 | 15.3 | 11.5 | 16.2 | 30.9 | 22.0 | 17.7 |
| Earnings yield | 7.6% | 6.6% | 7.0% | 5.2% | 5.8% | 3.7% | 4.4% | 4.6% | 5.2% | 3.8% |
| Free cash flow yield | 12.2% | 8.4% | 5.4% | 8.8% | 10.1% | 12.6% | 8.4% | 5.3% | 5.7% | 6.9% |
| Dividend yield | 1.5% | 1.4% | 1.2% | 1.4% | 1.8% | 1.5% | 1.7% | 1.8% | 1.6% | 1.4% |
| Shareholder yield (dividends + buybacks) | 10.9% | 11.6% | 6.7% | 6.0% | 6.5% | 2.1% | 5.5% | 4.1% | 7.0% | 6.3% |
| Share price at fiscal year-end | $101.76 | $108.28 | $127.66 | $103.78 | $82.03 | $96.03 | $87.77 | $67.14 | $76.65 | $81.42 |
| Per share | ||||||||||
| Revenue per share | $156.17 | $148.10 | $138.62 | $138.06 | $127.26 | $120.20 | $108.12 | $105.65 | $100.09 | $96.78 |
| Earnings per share | $7.70 | $7.17 | $8.88 | $5.38 | $4.77 | $3.56 | $3.83 | $3.11 | $4.02 | $3.12 |
| Operating cash flow per share | $13.10 | $9.78 | $7.37 | $9.53 | $8.92 | $12.86 | $7.76 | $4.17 | $4.88 | $5.95 |
| Free cash flow per share | $12.41 | $9.07 | $6.87 | $9.09 | $8.30 | $12.08 | $7.41 | $3.54 | $4.38 | $5.62 |
| Cash per share | $3.91 | $1.11 | $1.75 | $1.95 | $1.82 | $2.91 | $3.19 | $5.37 | $3.24 | $4.58 |
| Book value per share | $32.26 | $31.23 | $33.24 | $30.36 | $27.87 | $26.27 | $24.03 | $33.99 | $7.35 | $7.60 |
| Tangible book value per share | −$47.42 | −$40.65 | −$36.50 | −$39.89 | −$41.76 | −$40.60 | −$24.27 | −$32.29 | −$16.07 | −$15.56 |
| Dividends per share | $1.51 | $1.49 | $1.47 | $1.49 | $1.48 | $1.48 | $1.47 | $1.20 | $1.21 | $1.18 |
| Capex per share | $0.69 | $0.71 | $0.50 | $0.45 | $0.62 | $0.78 | $0.36 | $0.63 | $0.49 | $0.33 |
| Debt per share | $58.19 | $47.39 | $41.82 | $45.27 | $46.64 | $46.34 | $35.47 | $47.37 | $23.01 | $22.81 |
| Shares outstanding | 46.5M | 50.5M | 53.7M | 55.8M | 58.1M | 58.7M | 59.0M | 44.1M | 44.5M | 45.9M |
| Change in shares outstanding | −7.9% | −6.0% | −3.8% | −4.0% | −1.0% | −0.5% | +33.8% | −0.9% | −3.1% | −3.2% |
| Returns & profitability | ||||||||||
| Return on equity (ROE) | 23.3% | 21.5% | 27.4% | 18.1% | 17.5% | 14.1% | 15.5% | 15.0% | 53.0% | 39.2% |
| Return on invested capital (ROIC) | 12.5% | 12.2% | 14.2% | 9.7% | 8.7% | 8.2% | 8.9% | 7.8% | 17.9% | 14.5% |
| Return on assets (ROA) | 6.8% | 6.9% | 8.8% | 5.3% | 4.8% | 4.0% | 4.9% | 4.1% | 8.7% | 6.9% |
| Return on tangible assets | 21.7% | 22.4% | 30.4% | 18.5% | 16.3% | 11.6% | 12.1% | 8.4% | 17.4% | 14.6% |
| Free cash flow margin | 7.9% | 6.1% | 5.0% | 6.6% | 6.5% | 10.0% | 6.9% | 3.3% | 4.4% | 5.8% |
| Income quality (OCF / net income) | 1.70 | 1.36 | 0.83 | 1.77 | 1.87 | 3.61 | 2.03 | 1.34 | 1.21 | 1.91 |
| Financial health | ||||||||||
| Total debt | $2.71B | $2.39B | $2.25B | $2.53B | $2.71B | $2.72B | $2.09B | $2.09B | $1.02B | $1.05B |
| Cash & short-term investments | $182.0M | $56.0M | $94.0M | $109.0M | $106.0M | $171.0M | $188.0M | $237.0M | $144.0M | $210.0M |
| Net debt | $2.52B | $2.34B | $2.15B | $2.42B | $2.60B | $2.55B | $1.91B | $1.85B | $880.0M | $837.0M |
| Debt / equity | 1.80 | 1.52 | 1.26 | 1.49 | 1.67 | 1.76 | 1.48 | 1.39 | 3.13 | 3.00 |
| Debt / assets | 0.51 | 0.46 | 0.42 | 0.46 | 0.47 | 0.48 | 0.44 | 0.46 | 0.49 | 0.51 |
| Net debt / EBITDA | 3.82 | 3.41 | 2.44 | 3.72 | 4.15 | 4.46 | 3.76 | 6.86 | 2.89 | 2.64 |
| Current ratio | 1.20 | 0.83 | 0.98 | 1.06 | 0.93 | 1.01 | 1.27 | 1.60 | 1.37 | 1.45 |
| Quick ratio | 1.20 | 0.83 | 0.97 | 0.93 | 0.83 | 0.89 | 1.14 | 1.52 | 1.18 | 1.20 |
| Interest coverage | 3.9 | 3.9 | 6.2 | 4.2 | 4.4 | 3.2 | 4.1 | 4.2 | 5.8 | 5.1 |
| Working capital | $197.0M | −$242.0M | −$27.0M | $71.0M | −$89.0M | $14.0M | $302.0M | $536.0M | $255.0M | $278.0M |
| Invested capital | $4.02B | $3.91B | $3.94B | $4.11B | $4.22B | $4.09B | $3.32B | $3.35B | $1.21B | $1.19B |
| Tangible asset value | −$2.21B | −$2.05B | −$1.96B | −$2.22B | −$2.42B | −$2.37B | −$1.42B | −$1.42B | −$715.0M | −$709.0M |
| Net current asset value | −$2.67B | −$2.52B | −$2.40B | −$2.64B | −$2.85B | −$2.88B | −$1.85B | −$1.63B | −$796.0M | −$787.0M |
| Graham number | $74.75 | $70.97 | $81.51 | $60.60 | $54.67 | $45.87 | $45.51 | $48.74 | $25.79 | $23.09 |
| Graham net-net per share | −$65.21 | −$56.69 | −$51.17 | −$52.90 | −$54.71 | −$54.52 | −$37.29 | −$45.41 | −$23.16 | −$21.74 |
| Capital allocation | ||||||||||
| Dividends paid | $70.0M | $75.0M | $79.0M | $83.0M | $86.0M | $87.0M | $87.0M | $53.0M | $54.0M | $54.0M |
| Share buybacks (net) | $445.0M | $558.0M | $382.0M | $267.0M | $226.0M | $34.0M | $197.0M | $69.0M | $186.0M | $180.0M |
| Dividend payout ratio | 19.6% | 20.7% | 16.6% | 27.7% | 31.0% | 41.6% | 38.5% | 38.7% | 30.2% | 37.8% |
| Dividends + buybacks / free cash flow | 89.3% | 138.2% | 124.9% | 69.0% | 64.7% | 17.1% | 65.0% | 78.2% | 123.1% | 90.7% |
| Capex / revenue | 0.4% | 0.5% | 0.4% | 0.3% | 0.5% | 0.7% | 0.3% | 0.6% | 0.5% | 0.3% |
| Capex / operating cash flow | 5.3% | 7.3% | 6.8% | 4.7% | 6.9% | 6.1% | 4.6% | 15.2% | 10.1% | 5.5% |
| Capex / depreciation | 0.21 | 0.26 | 0.19 | 0.16 | 0.22 | 0.26 | 0.15 | 0.60 | 0.48 | 0.28 |
| Stock-based compensation / revenue | 0.9% | 0.7% | 0.9% | 0.6% | 0.6% | 0.6% | 0.6% | 1.0% | 0.6% | 0.7% |
| R&D / revenue | 0.3% | 0.5% | 0.1% | 0.0% | 0.1% | 0.1% | 0.1% | 0.1% | 0.1% | 0.1% |
| SG&A / revenue | 4.8% | 4.5% | 5.0% | 4.9% | 4.7% | 5.0% | 4.5% | 3.4% | 3.2% | 3.9% |
| Efficiency | ||||||||||
| Days sales outstanding | 46.6 | 46.7 | 45.4 | 46.2 | 48.8 | 53.3 | 61.5 | 67.5 | 49.7 | 48.2 |
| Days of inventory on hand | — | — | 4.3 | 7.9 | 8.3 | 8.7 | 7.0 | 9.0 | 12.8 | 12.5 |
| Days payables outstanding | 32.3 | 33.2 | 33.1 | 33.1 | 31.5 | 30.4 | 31.6 | 37.1 | 32.8 | 31.0 |
| Cash conversion cycle (days) | 14.2 | 13.5 | 16.6 | 21.0 | 25.6 | 31.6 | 36.9 | 39.4 | 29.8 | 29.7 |
| Receivables turnover | 7.84 | 7.82 | 8.05 | 7.90 | 7.48 | 6.85 | 5.94 | 5.40 | 7.34 | 7.57 |
| Payables turnover | 11.29 | 11.00 | 11.04 | 11.03 | 11.58 | 12.00 | 11.55 | 9.85 | 11.14 | 11.77 |
| Inventory turnover | — | — | 84.80 | 46.37 | 43.86 | 41.90 | 52.29 | 40.73 | 28.47 | 29.22 |
| Asset turnover | 1.37 | 1.42 | 1.37 | 1.36 | 1.29 | 1.35 | 1.38 | 1.40 | 2.16 | 2.13 |
| Average receivables | $926.5M | $957.0M | $925.0M | $975.5M | $988.5M | $1.03B | $1.07B | $862.0M | $606.5M | $587.0M |
| Average payables | $565.5M | $599.0M | $595.5M | $618.0M | $564.5M | $522.0M | $491.0M | $426.0M | $363.0M | $340.0M |
| Average inventory | — | — | $77.5M | $147.0M | $149.0M | $149.5M | $108.5M | $103.0M | $142.0M | $137.0M |
| Intangibles / total assets | 69.2% | 69.2% | 70.5% | 70.7% | 70.4% | 68.6% | 60.5% | 64.1% | 50.3% | 52.1% |
Computed from SAIC's annual financial statements (latest annual report filed March 16, 2026) and the closing share price on each fiscal year-end, adjusted for stock splits. Figures in U.S. dollars; data from EODHD. Averages use the opening and closing balance of each year.
SAIC valuation and financial ratios
At the end of fiscal 2026 (January 31, 2026), Science Applications International traded at 13.2 times earnings, against a 10-year median of 19.2. Based on the latest twelve months, the trailing P/E is 15.5 and the forward P/E is 10.6. Science Applications International earned a return on equity of 23.3% and a return on invested capital of 12.5% in fiscal 2026. It ended the year with $2.7 billion of debt and $182.0 million in cash and short-term investments, net debt of $2.5 billion. It returned $515.0 million to shareholders: $70.0 million in dividends and $445.0 million in share buybacks, 89% of free cash flow.
See the SAIC income statement, the SAIC chart for price history, or the SAIC stock overview for the latest quote and news.
SAIC key metrics FAQ
What is Science Applications International's P/E ratio?
Science Applications International's trailing P/E ratio is 15.5 based on the last twelve months of earnings (as of October 17, 2026), and its forward P/E is 10.6. At the end of fiscal 2026 it was 13.2, compared with a 10-year median of 19.2.
What is Science Applications International's EV/EBITDA?
Science Applications International's enterprise value was 11.0 times EBITDA at the end of fiscal 2026 (enterprise value $7.3 billion, EBITDA $661.0 million); the current EV/EBITDA is 10.9.
What is Science Applications International's return on equity?
Science Applications International's return on equity (ROE) was 23.3% in fiscal 2026: net income of $358.0 million on average shareholders' equity of $1.5 billion.
What is Science Applications International's ROIC?
Science Applications International's return on invested capital was 12.5% in fiscal 2026, using after-tax operating income divided by average debt plus equity minus cash.
How much debt does Science Applications International have?
Science Applications International had total debt of $2.7 billion at the end of fiscal 2026, a debt-to-equity ratio of 1.80 and $2.5 billion of net debt (3.82 times EBITDA).
What is Science Applications International's dividend yield?
Science Applications International's forward dividend yield is 1.11%. Science Applications International paid $70.0 million in dividends in fiscal 2026 ($1.51 per share), a payout ratio of 19.6%.
Does Science Applications International buy back its shares?
Yes. Science Applications International spent $445.0 million on net share repurchases in fiscal 2026 Shares outstanding changed −7.9% over the year, to 46.5M..
What is Science Applications International's free cash flow yield?
Science Applications International generated $577.0 million of free cash flow in fiscal 2026, a free cash flow yield of 12.2% on its market value at year-end ($4.7 billion).
What is Science Applications International's current ratio?
Science Applications International's current ratio was 1.20 at the end of fiscal 2026: current assets were 1.20 times current liabilities.